Using surgical mesh to prevent hernias after bladder cancer surgery
The Use of Surgical Mesh in Open Radical Cystectomy With Ileal Conduit Urinary Diversion to Prevent Parastomal Hernias
This study tests whether using surgical mesh during bladder cancer surgery can help prevent hernias in patients who have had this procedure.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Charles University, Czech Republic Academic / other |
| Locations | 1 site (Hradec Králové) |
| Trial ID | NCT06032910 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of surgical mesh during radical cystectomy with ileal conduit urinary diversion to prevent the occurrence of parastomal hernias, a common complication that can significantly affect patients' quality of life. The trial compares outcomes between patients receiving mesh placement and those in a control group without mesh. By focusing on this under-researched area, the study aims to provide evidence for a potential prophylactic intervention that could improve surgical outcomes. The incidence of parastomal hernias is notably high, prompting the need for innovative solutions in surgical practices.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with muscle-invasive or high-risk non-muscle-invasive bladder cancer who are undergoing radical cystectomy.
Not a fit: Patients who are not undergoing surgical therapy for bladder cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of parastomal hernias and improve the quality of life for patients undergoing bladder cancer surgery.
How similar studies have performed: While there is limited evidence regarding the use of prophylactic mesh for parastomal hernia prevention specifically in radical cystectomy, similar approaches in other types of stoma surgeries have shown promise.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * muscle-invasive or high-risk non-muscle-invasive bladder cancer patients Exclusion Criteria: * different than surgical therapy
Where this trial is running
Hradec Králové
- University Hospital Hradec Kralove — Hradec Králové, Czechia (Recruiting)
Study contacts
- Study coordinator: Pavel Navratil, M.D.
- Email: pavel.navratil2@fnhk.cz
- Phone: 00420495833378
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.